ERECTILE DYSFUNCTION - PowerPoint PPT Presentation

1 / 46
About This Presentation
Title:

ERECTILE DYSFUNCTION

Description:

Taldafil (Cialis) Vardenafil (Levitra) ERECTILE DYSFUNCTION. PDE5 Inhibitors ... Cialis. Not within 2 hrs. 4 - 6 hrs. 50 100 mg. Viagra. Food. Duration of ... – PowerPoint PPT presentation

Number of Views:7835
Avg rating:3.0/5.0
Slides: 47
Provided by: helen66
Category:

less

Transcript and Presenter's Notes

Title: ERECTILE DYSFUNCTION


1
ERECTILE DYSFUNCTION
  • HELEN CROWE
  • UROLOGY NURSE CLINICIAN / RESEARCH NURSE
  • ROYAL MELBOURNE HOSPITAL

2
SEXUAL DYSFUNCTIONMALE ERECTILE DYSFUNCTION
  • Anatomy Physiology
  • Prevalence of ED its impact
  • Causes
  • Investigations
  • Treatment options
  • Nursing role

3
ERECTILE DYSFUNCTION (ED)
  • Previously known as impotence
  • The consistent inability to achieve and/or
    maintain an erection adequate for satisfactory
    sexual intercourse

4
(No Transcript)
5
(No Transcript)
6
(No Transcript)
7
PENILE ANATOMY
  • 3 cylindrical erectile bodies 2 paired corpora
    cavernosa and corpus spongiosum surrounding the
    urethra
  • Corpora cavernosa separated by common medial
    septum perforated elastic tissue allows for
    shared circulation
  • Erectile tissue lattice of vascular lacunar
    sinusoids,surrounded by smooth muscle
  • Penile skin loosely adherent and flexible to
    permit expansion

8
PENILE VASCULATURE
  • ARTERIAL SUPPLY Cavernosal arteries run down
    centre of each corpus cavernosum, giving off
    multiple helicine arteries which open directly
    into lacunar spaces.
  • VENOUS DRAINAGE Subtunical venules compressed
    during erection

9
PENILE NEURO-ANATOMY
  • Innervation both sympathetic and parasympathetic,
    sensory and motor.
  • Parasympathetic nervous system responsible for
    vasodilation of penile arteries and erection.
  • Sympathetic nervous system controls detumescence
    and maintains flaccidity.

10
(No Transcript)
11
PHYSIOLOGY OF ERECTIONS
  • SEXUAL STIMULATION
  • DECREASED PERIPHERAL RESISTANCE
  • INCREASED ARTERIAL BLOOD FLOW
  • RAISED INTRACAVERNOSAL PRESSURE
  • RELAXATION OF VASCULAR SMOOTH MUSCLE
  • LACUNAR ENGORGEMENT AND ERECTION

12
(No Transcript)
13
ERECTILE DYSFUNCTION PREVALENCE
14
ERECTILE DYSFUNCTION
  • Dramatic impact on quality of life of men and
    their partners significant morbidity for
    affected couples who desire sexual activity
  • Often over-looked, ignored
  • Frequently results in anxiety, depression, lack
    of self-esteem

15
ERECTILE DYSFUNCTION SURVEYCrowe, 2001
  • The sexual aspect of our marriage has had to
    change.. a lot of compromising. The closeness
    that was there has certainly been affected.
  • We had a very good physical relationship. Since
    the surgery, not being able to get an erection,
    all the loving, touching, closeness has stopped.
  • Thank you for asking! At last somebody is
    assessing this unhappy situation.

16
  • Modern drug therapy for ED was advanced
    enormously in 1983 when British physiologist
    Giles Brindley, Ph.D. dropped his trousers and
    demonstrated to a shocked AUA audience his
    phentolamine-induced erection

17
ERECTILE DYSFUNCTION CAUSES
  • Organic
  • Psychogenic
  • Often combination of both

18
ERECTILE DYSFUNCTION ORGANIC CAUSES
  • Vasculogenic
  • Neurogenic
  • Endocrine
  • Drug-related

19
ERECTILE DYSFUNCTIONVASCULOGENIC CAUSES
  • ATHEROSCLEROSIS
  • PVD
  • Hypertension
  • Coronary Artery Disease
  • VENOUS LEAK
  • Veno-occlusive defect able to get, but unable to
    maintain erection

20
ERECTILE DYSFUNCTIONNEUROGENIC CAUSES
  • Peripheral neuropathy
  • Spinal cord injury
  • Pelvic surgery cystectomy, radical prostatectomy,
    aorto-bifem graft, abdo-perineal resection,
    anterior resection
  • Pelvic radiotherapy

21
ERECTILE DYSFUNCTIONENDOCRINE CAUSES
  • Diabetes
  • Hyperlipidaemia
  • Rarely Se Testosterone deficiency

22
ERECTILE DYSFUNCTIONDRUG-RELATED CAUSES
  • SUBSTANCE ABUSE
  • Alcohol
  • Smoking
  • Cannabis

23
ERECTILE DYSFUNCTIONDRUG-RELATED CAUSES
  • PRESCRIPTION DRUGS
  • Thiazide diuretics
  • Antihypertensives
  • Cardiac drugs
  • Antidepressants
  • Tranquilisers
  • H2 agonists
  • Anticholinergics

24
ERECTILE DYSFUNCTIONINVESTIGATIONS
  • Medical history, physical exam r/o undiagnosed
    reversible cause
  • Psychological assessment
  • Sexual history onset circumstances
  • Tests rarely performed.
  • Rigiscan (nocturnal tumescence monitoring)
  • Doppler Ultrasound (Vascular ED)
  • Cavernosography (Venous leak)

25
ORGANIC ERECTILE DYSFUNCTIONTREATMENT OPTIONS
  • Drug therapy
  • Medical devices
  • Surgery

26
ERECTILE DYSFUNCTIONDRUG THERAPY
  • Intracavernosal injections
  • Intra-urethral pellets
  • Oral agents
  • Topical gels (experimental)
  • Nasal spray

27
ERECTILE DYSFUNCTION INTRACAVERNOSAL INJECTIONS
  • Prostaglandin E1 (Caverject)
  • Papaverine
  • Cocktails
  • MODE of ACTION
  • Cavernosal smooth muscle relaxation

28
(No Transcript)
29
(No Transcript)
30
ERECTILE DYSFUNCTIONPROSTAGLANDIN E1
  • Rapid onset of response (5 - 15 after injection)
  • No sexual stimulation required
  • At right dose, erection for 30 - 45
  • Discreet use possible
  • Cost factor

31
ERECTILE DYSFUNCTIONPROSTAGLANDIN E1
  • Dose-response effect, titration required
  • Patient education re technique
  • 80 successful
  • SIDE EFFECTS
  • Pain
  • Priapism
  • Corporal fibrosis

32
ERECTILE DYSFUNCTION INTRA-URETHRAL
PELLETSPROSTAGLANDIN E1 (MUSE)
  • Easy administration
  • Dose titration necessary
  • Patient education required
  • Moist urethra .. void prior to pellet insertion
  • Onset of response 20
  • Erection lasting 30 - 60
  • 50 - 60 successful

33
(No Transcript)
34
ERECTILE DYSFUNCTION INTRA-URETHRAL
PELLETSPROSTAGLANDIN E1 (MUSE)
  • SIDE EFFECTS
  • Local pain, urethral burning
  • Vaso-vagal episodes
  • Minor urethral bleeding

35
ERECTILE DYSFUNCTIONPDE5 Inhibitors
  • Sildenafil (Viagra)
  • Taldafil (Cialis)
  • Vardenafil (Levitra)

36
ERECTILE DYSFUNCTIONPDE5 Inhibitors
  • Enhance and potentiate corporal smooth muscle
    relaxation
  • Active sexual stimulation necessary
  • 1 hour prior to planned intercourse
  • Effective 70 - 90
  • Intact neurovascular bundle necessary ? not good
    post RRP
  • Expensive

37
ERECTILE DYSFUNCTION PDE 5 Inhibitors
  • SIDE EFFECTS
  • Headache
  • Facial flushing
  • Visual disturbances color perception (inhibition
    of PDE6 in retina, Viagra only)
  • Dyspepsia
  • Nasal congestion/ stuffiness
  • C/Initrate Rx hypotension

38
ERECTILE DYSFUNCTION PDE 5 Inhibitors
39
ERECTILE DYSFUNCTIONApomorphine (Uprima)
  • Dopamine agonist, works on CNS
  • Dose 2 4 mg S/L 10 20 prio to sexual
    activity
  • Onset of action 10
  • Duration of action 30
  • Effective 55 60
  • S/E nausea (40), vomiting (11), dizziness
    (20), somnolence (10), sweatiness (18),
    hypotension (4)

40
ERECTILE DYSFUNCTIONApomorphine Nasal Spray
  • Intranasal delivery of apomorphine
  • ? Combination with phentolamine
  • ? Dose
  • ? Cost
  • ? Availability
  • ?? Clinical trials
  • ??? Secrecy

41
ERECTILE DYSFUNCTIONMEDICAL DEVICES
  • VACUUM ERECTION DEVICES (VED)
  • Negative pressure on the penis, draws blood into
    the penis
  • erection
  • Constriction band at base of penis to maintain
    erection
  • 2 - 10 to produce erection
  • Band in place no more than 30

42
(No Transcript)
43
ERECTILE DYSFUNCTIONMEDICAL DEVICES (VED)
  • PROS
  • One off expense
  • Easily portable
  • CONS
  • Expensive
  • Not discreet, not spontaneous
  • Discomfort

44
ERECTILE DYSFUNCTIONSURGICAL TREATMENT
  • Last resort treatment option, no returning to
    other options
  • Penile prostheses non-hydraulic and hydraulic
  • Non-hydraulic semi-rigid rods
  • Hydraulic hollow inflatable cylinders
  • Expensive

45
ERECTILE DYSFUNCTIONPENILE PROSTHESES
  • Pre-operative careful counselling
  • 2 - 3 days hospitalisation
  • Prosthesis not activated for 6 weeks
  • COMPLICATONS
  • Infection
  • Erosion
  • Component failure (rare)

46
ERECTILE DYSFUNCTIONNURSING ROLE
  • Awareness of the high incidence of ED, impact on
    quality of life of patients and partners
  • Knowledge of potential causative factors,
    awareness of high risk patients
  • Discussion with medical staff re patient
    information education
  • Willingness to discuss, refer on prn
Write a Comment
User Comments (0)
About PowerShow.com